

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1629, 2008-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Anti-TNF therapy: which variables affect cost?
Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. :


Anti-TNF therapy: which variables affect cost?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 546, 2008-01 ,pp. :


Paclitaxel treatment does not appear to affect the risk of epirubicin-related cardiotoxicity
Reactions Weekly, Vol. 1, Iss. 1017, 2004-01 ,pp. :